RJA
VXRT

Raymond James & Associates’s Vaxart VXRT Stock Holding History

Raymond James & Associates’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$10.4K Sell
12,279
-4,447
-27% -$3.4K ﹤0.01% 3968
2024
Q2 		$11.2K Sell
16,726
-131
-0.8% -$109 ﹤0.01% 3926
2024
Q1 		$21.9K Sell
16,857
-131
-0.8% -$137 ﹤0.01% 3865
2023
Q4 		$9.73K Sell
16,988
-500
-3% -$346 ﹤0.01% 3793
2023
Q3 		$13.2K Sell
17,488
-250
-1% -$190 ﹤0.01% 3751
2023
Q2 		$12.9K Buy
17,738
+7,616
+75% +$7.08K ﹤0.01% 3797
2023
Q1 		$7.66K Sell
10,122
-500
-5% -$464 ﹤0.01% 3847
2022
Q4 		$10.2K Sell
10,622
-2,271
-18% -$3.21K ﹤0.01% 3843
2022
Q3 		$28K Sell
12,893
-288
-2% -$993 ﹤0.01% 3767
2022
Q2 		$46K Buy
13,181
+288
+2% +$1.08K ﹤0.01% 3798
2022
Q1 		$65K Sell
12,893
-275
-2% -$1.39K ﹤0.01% 3891
2021
Q4 		$83K Sell
13,168
-24,850
-65% -$170K ﹤0.01% 3891
2021
Q3 		$302K Buy
38,018
+100
+0.3% +$823 ﹤0.01% 3414
2021
Q2 		$284K Buy
37,918
+7,388
+24% +$51.6K ﹤0.01% 3475
2021
Q1 		$185K Sell
30,530
-7,387
-19% -$56.8K ﹤0.01% 3637
2020
Q4 		$217K Buy
37,917
+27,401
+261% +$174K ﹤0.01% 3341
2020
Q3 		$70K Buy
+10,516
New +$93.7K ﹤0.01% 3424

Other funds holding VXRT

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James & Associates's VXRT Position: Q3 2024 in Review

Raymond James & Associates reduced its Vaxart (VXRT) stake by 27% in Q3 2024, selling an estimated $3.4K and leaving 12,279 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3968.

Raymond James & Associates first reported a position in VXRT in Q3 2020 and has held it in 17 quarters since. The position peaked at $302K in Q3 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

  • Raymond James & Associates held 12,279 shares of Vaxart worth $10.4K as of Q3 2024.
  • Raymond James & Associates sold 4,447 Vaxart shares in Q3 2024, an estimated $3.4K.
  • Vaxart made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3968 holding.
  • Raymond James & Associates first reported a position in Vaxart in Q3 2020 and has held it in 17 quarters since.
  • Raymond James & Associates's Vaxart position peaked at $302K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.